← Xtant Medical Holdings, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $90.0m |
$82.6m
-8.21%
|
$72.2m
-12.60%
|
$64.7m
-10.42%
|
$53.3m
-17.54%
|
$55.3m
+3.61%
|
$58.0m
+4.90%
|
$91.3m
+57.50%
|
$117.3m
+28.44%
|
$133.9m
+14.21%
|
$121.9m
-8.98%
|
|
| Revenue from Contract with Customer, Including Assessed Tax | — | — | $71.8m | $64.5m | — | — | — | — | — | — | — | |
| Cost of Revenue | $27.7m |
$32.5m
+17.33%
|
$28.7m
-11.67%
|
$22.2m
-22.81%
|
$18.9m
-14.53%
|
$22.8m
+20.21%
|
$25.8m
+13.43%
|
$35.8m
+38.73%
|
$49.1m
+36.88%
|
$49.7m
+1.23%
|
$45.9m
-7.55%
|
|
| Gross Profit | $62.3m |
$50.1m
-19.57%
|
$43.5m
-13.20%
|
$42.5m
-2.23%
|
$34.4m
-19.11%
|
$32.5m
-5.53%
|
$32.1m
-1.09%
|
$55.5m
+72.60%
|
$68.2m
+22.98%
|
$84.3m
+23.54%
|
$76.0m
-9.82%
|
|
| Research and Development Expense | $3.4m | $2.4m | $1.7m | $932k | $657k | $870k | $915k | $1.3m | $2.4m | $2.1m | $2.1m | |
| Selling and Marketing Expense | $44.1m | $40.5m | $32.1m | $25.8m | $21.0m | $21.0m | $22.5m | $38.4m | $49.2m | $45.5m | $70.6m | |
| General and Administrative Expense | $15.8m | $15.2m | $12.9m | $17.9m | $13.5m | $14.4m | $15.5m | $25.9m | $28.7m | $29.4m | $28.1m | |
| Amortization of Intangible Assets | $4.5m | $4.6m | $2.5m | $58k | $100k | $100k | $100k | $1.4m | $1.7m | $1.6m | — | |
| Operating Lease, Expense | — | — | — | $588k | $600k | $600k | $600k | $700k | $900k | $1.2m | — | |
| Operating Expenses | $69.8m | $87.9m | $103.6m | $44.8m | $35.1m | $36.3m | $38.9m | $65.6m | $80.3m | $77.0m | $72.7m | |
| Operating Income (Loss) | ($7.5m) |
($37.8m)
-401.43%
|
($60.1m)
-58.79%
|
($2.3m)
+96.25%
|
($751k)
+66.67%
|
($3.9m)
-413.18%
|
($6.8m)
-75.27%
|
($10.2m)
-50.38%
|
($12.1m)
-18.86%
|
$7.3m
+160.33%
|
$3.3m
-54.72%
|
|
| Gain (Loss) on Derivative Instruments, Net, Pretax | $717k | $203k | — | — | — | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | ($352k) | ($75k) | $3k | ($101k) | — | — | — | — | ($33k) | $73k | — | |
| Interest Expense (non-operating) | $12.3m | $14.7m | $10.1m | $5.8m | $6.0m | $995k | $1.7m | $2.9m | $4.2m | $3.7m | $3.2m | |
| Other Expenses | — | — | — | — | — | — | — | $49k | $33k | — | — | |
| Other Income | — | — | $389k | $166k | $149k | $117k | $11k | — | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($19.4m) | ($52.4m) | ($70.1m) | ($8.1m) | ($6.7m) | ($4.8m) | ($8.4m) | ($1.0m) | ($16.3m) | $7.0m | $3.9m | |
| Current Income Tax Expense (Benefit) | $50k | $0 | — | $98k | $296k | — | — | $204k | $166k | $2.1m | $2.1m | |
| Income Tax Expense (Benefit) | $50k | $0 | — | ($98k) | $296k | — | $69k | ($1.7m) | $187k | $2.0m | $2.1m | |
| Net Income (Loss) Attributable to Parent | ($19.5m) |
($52.4m)
-168.86%
|
($70.1m)
-33.75%
|
($8.2m)
+88.27%
|
($7.0m)
+14.57%
|
($4.8m)
+30.96%
|
($8.5m)
-74.98%
|
$660k
+107.78%
|
($16.4m)
-2592.27%
|
$5.0m
+130.23%
|
$1.8m
-63.28%
|
|
| Earnings Per Share, Basic | ($1.54) | ($34.76) | ($5.97) | ($0.63) | ($0.25) | ($0.06) | ($0.09) | $0.01 | ($0.12) | $0.04 | $0.02 | |
| Earnings Per Share, Diluted | ($1.54) | ($34.76) | ($5.97) | ($0.63) | ($0.25) | ($0.06) | ($0.09) | $0.01 | ($0.12) | $0.03 | $0.01 | |
| Weighted Average Number of Shares Outstanding, Basic | 12.7m | 1.5m | 11.7m | 13.2m | 28.5m | 85.5m | 94.1m | 119.1m | 133.7m | 139.5m | 139.8m | |
| Weighted Average Number of Shares Outstanding, Diluted | 12.7m | 1.5m | 11.7m | 13.2m | 28.5m | 85.5m | 94.1m | 126.8m | 133.7m | 150.0m | 149.2m | |
| Additional Financial Items | ||||||||||||
| Cost of Property Repairs and Maintenance | $588k | — | — | — | — | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | — | — | $38.3m | — | — | — | — | — | — | — | $0 |